The New England Journal of Medicine pulled an article slamming the National Kidney Foundation for its reliance on drug company donations, the Wall Street Journal reported.

Genentech has agreed to acquire its Xolair co-marketer, the Houston-based biotech firm Tanox, in a deal worth $919 million.

OTC Plan B is launching with detailing and professional ads, but the campaign will include a nod to consumers, too.

The AARP has launched a $500,000 ad campaign in 14 states pushing for Senate action on legislation to let consumers buy US-made Rx drugs from Canada.

WebMD Health has entered into a deal to acquire the interactive medical education, promotion and physician recruitment businesses of Medsite.

Just days after an announced crackdown on researchers who fail to disclose their ties to drug makers, the editor of the Journal of the American Medical Association (JAMA) said she has been misled again, this time by the authors of a study linking severe migraines to heart attacks in women.

Sunrise Senior Living, the nation’s largest senior care franchise, has hired Haymarket Media to publish Sunrise Magazine, a title aimed at caregivers.

Pfizer retracted a remark made by its chief executive this morning that Exubera was approved in the US.

The federal judge overseeing Vioxx litigation ruled this week that Merck would be allowed to depose the executive editor of the New England Journal of Medicine (NEJM), according to a report in The Wall Street Journal (WSJ) this week.

Roche has been running radio spots in the U.S. for its antiviral drug Tamiflu, even as other countries are plagued by shortages, The Wall Street Journal reports.